EIRNov 4, 2022

EIR Document: Boehringer Ingelheim Fremont, Inc.

Jeffrey P. Raimondi, FDA Investigator Christopher R. Czajka, FDA Investigator

FDANews EIR Boehringer Ingelheim Fremont, Inc. Nov 4 2022 top

Jeffrey P. Raimondi FDA Investigator Christopher R. Czajka FDA Investigator

Establishment Inspection Report for the FDA inspection at Boehringer Ingelheim Fremont, Inc.'s Fremont site on Nov 04, 2022. Get detailed insights.